135 related articles for article (PubMed ID: 29925110)
21. Cervical cancer screening in Greenland, 1997-2011: Screening coverage and trends in the incidence of high-grade cervical lesions.
Holst S; Wohlfahrt J; Kjær SK; Kamper-Jørgensen M; Kern P; Andersson M; Koch A
Gynecol Oncol; 2016 Nov; 143(2):307-312. PubMed ID: 27018418
[TBL] [Abstract][Full Text] [Related]
22. Level of human development is associated with cervical cancer stage at diagnosis.
Vale DB; Sauvaget C; Muwonge R; Thuler LCS; Basu P; Zeferino LC; Sankaranarayanan R
J Obstet Gynaecol; 2019 Jan; 39(1):86-90. PubMed ID: 30229689
[TBL] [Abstract][Full Text] [Related]
23. Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Baldauf JJ; Fender M; Bergeron C; Marrer E; Velten M; Pradat P; Arbyn M
Eur J Cancer Prev; 2019 Jan; 28(1):33-39. PubMed ID: 29135538
[TBL] [Abstract][Full Text] [Related]
24. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.
Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L
Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155
[TBL] [Abstract][Full Text] [Related]
25. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
Vale DB; Braganca JF; Morais SS; Zeferino LC
Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
[TBL] [Abstract][Full Text] [Related]
26. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme.
Bucchi L; Mancini S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; de Bianchi PS; Ferretti S;
J Med Screen; 2020 Jun; 27(2):96-104. PubMed ID: 31690178
[TBL] [Abstract][Full Text] [Related]
27. Differences in cervical cancer screening between immigrants and nonimmigrants in Norway: a primary healthcare register-based study.
Møen KA; Kumar B; Qureshi S; Diaz E
Eur J Cancer Prev; 2017 Nov; 26(6):521-527. PubMed ID: 27749381
[TBL] [Abstract][Full Text] [Related]
28. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
30. Trends in cervical cancer mortality rate in women aged 20 years and older in Brazil from 2005 to 2019.
de Oliveira GS; da Silva GRP; Aquino MLC; Dos Santos Oliveira F; Silva GO; Del Angelo Aredes N; Guimarães RA
Women Health; 2022 Jul; 62(6):532-543. PubMed ID: 35818165
[TBL] [Abstract][Full Text] [Related]
31. Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study.
Teixeira JC; Vale DB; Discacciati MG; Campos CS; Bragança JF; Zeferino LC
Rev Bras Ginecol Obstet; 2023 Jan; 45(1):21-30. PubMed ID: 36878249
[TBL] [Abstract][Full Text] [Related]
32. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
33. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
34. Linear trend analysis of patients with cervical cancer treated at the Institute of Oncology Vojvodina in 2001-2007.
Nincic D; Mandic A; Dugandzija T; Zivaljevic M; Rajovic J; Vojinovic D
J BUON; 2009; 14(4):669-72. PubMed ID: 20148460
[TBL] [Abstract][Full Text] [Related]
35. Screening for cervical cancer in imprisoned women in Brazil.
da Silva ERP; de Souza AS; de Souza TGB; Tsuha DH; Barbieri AR
PLoS One; 2017; 12(12):e0187873. PubMed ID: 29252994
[TBL] [Abstract][Full Text] [Related]
36. Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005-2020.
Shin HY; Lee YY; Song SY; Park B; Suh M; Choi KS; Jun JK
J Gynecol Oncol; 2022 Jul; 33(4):e39. PubMed ID: 35320888
[TBL] [Abstract][Full Text] [Related]
37. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
38. Is the age of cervical cancer diagnosis changing over time?
Gnade CM; Hill EK; Botkin HE; Hefel AR; Hansen HE; Sheets KA; Mott SL; Hardy-Fairbanks AJ; Stockdale CK
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102040. PubMed ID: 33316464
[TBL] [Abstract][Full Text] [Related]
39. Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.
Sasieni P; Castanon A
J Med Screen; 2012 Sep; 19(3):127-32. PubMed ID: 23093730
[TBL] [Abstract][Full Text] [Related]
40. Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
Stojanovic MM; Rancic NK; Andjelković Apostolović MR; Ignjatović AM; Stojanovic DR; Mitic Lakusic VR; Ilic MV
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208629
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
